Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

BRCA1 Produits

(Breast Cancer 1 (BRCA1))
This gene encodes a nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2009].

antibodies-online.com est synonyme de produits de recherche de haute qualité. Cherchez, trouvez et commandez des outils avec des données de validation étendues, des images, des références. Notre service clientèle scientifique est toujours à votre disposition si vous avez des questions sur la sélection ou l'application de nos produits.

Catégories BRCA1 en vedette

BRCA1 Anticorps

High quality antibodies with extensive validation data.

BRCA1 Kits ELISA

Reliable ELISA kits for a wide range of species.

BRCA1 Protéines

Proteins for various applications incl. WB, ELISA, IF etc.

BRCA1 recommandé Anticorps

Produit
Reactivity
Application
Validations
N° du produit
Quantité
Fiche technique
Reactivity Human
Application WB, IHC, IP, ICC
Validations
  • (6)
N° du produit ABIN7433579
Quantité 100 μL
Fiche technique Fiche technique
Reactivity Human, Mouse, Rat
Application WB, IHC, IF
Validations
  • (7)
N° du produit ABIN7265138
Quantité 200 μL
Fiche technique Fiche technique
Reactivity Human
Application WB, IHC, ELISA
Validations
  • (1)
  • (5)
N° du produit ABIN1724848
Quantité 0.1 mg
Fiche technique Fiche technique

BRCA1 recommandé Kits ELISA

Produit
Reactivity
Analytical Method
Validations
N° du produit
Quantité
Fiche technique
Reactivity Human
Analytical Method Quantitative Sandwich ELISA
Validations
  • (1)
N° du produit ABIN6965234
Quantité 96 tests
Fiche technique Fiche technique
Reactivity Human
Analytical Method Quantitative Sandwich ELISA
Validations
  • (1)
N° du produit ABIN6954188
Quantité 96 tests
Fiche technique Fiche technique
Reactivity Human
Analytical Method Qualitative Cell ELISA
Validations
N° du produit ABIN1380829
Quantité 2 x 96 tests
Fiche technique Fiche technique

BRCA1 recommandé Protéines

Produit
Reactivity
Source
Validations
N° du produit
Quantité
Fiche technique
Reactivity Human
Source Wheat germ
Validations
  • (1)
N° du produit ABIN1346845
Quantité 10 μg
Fiche technique Fiche technique
Reactivity Human
Source Wheat germ
Validations
  • (1)
N° du produit ABIN1346847
Quantité 10 μg
Fiche technique Fiche technique
Reactivity Human
Source Escherichia coli (E. coli)
Validations
N° du produit ABIN7504943
Quantité 100 μg
Fiche technique Fiche technique

Dernières publications sur nos produits BRCA1

Bodo, Campagne, Thin, Higginson, Vargas, Hua, Fuller, Ackerstaff, Russell, Zhang, Klingler, Cho, Kaag, Mazaheri, Rimner, Manova-Todorova, Epel, Zatcky, Cleary, Rao, Yamada, Zelefsky, Halpern et al.: "Single-dose radiotherapy disables tumor cell homologous recombination via ischemia/reperfusion injury. ..." dans: The Journal of clinical investigation, Vol. 129, Issue 2, pp. 786-801, (2019) (PubMed).

Yin, Liu, Peng, Peng, Yu, Gao, Yuan, Zhu, Cao, He, Gong, Sun, Fan, Li: "PARP inhibitor veliparib and HDAC inhibitor SAHA synergistically co-target the UHRF1/BRCA1 DNA damage repair complex in prostate cancer cells." dans: Journal of experimental & clinical cancer research : CR, Vol. 37, Issue 1, pp. 153, (2018) (PubMed).

Penn, Yang, Zong, Lim, Cole, Yang, Baker, Goonewardena, Buckanovich: "Therapeutic Impact of Nanoparticle Therapy Targeting Tumor-Associated Macrophages." dans: Molecular cancer therapeutics, Vol. 17, Issue 1, pp. 96-106, (2018) (PubMed).

Zhai, Steinø, Bacha, Brown, Daugaard: "Dianhydrogalactitol induces replication-dependent DNA damage in tumor cells preferentially resolved by homologous recombination." dans: Cell death & disease, Vol. 9, Issue 10, pp. 1016, (2018) (PubMed).

Liu, Lai, Li, Sun, Cheng, Ge, Wang, Li, Zhang, De Felici, Dyce, Shen: "Di (2-ethylhexyl) phthalate exposure impairs meiotic progression and DNA damage repair in fetal mouse oocytes in vitro." dans: Cell death & disease, Vol. 8, Issue 8, pp. e2966, (2017) (PubMed).

Wang, He, Wu, Li, Gao, Zeng: "Artemisinin mimics calorie restriction to trigger mitochondrial biogenesis and compromise telomere shortening in mice." dans: PeerJ, Vol. 3, pp. e822, (2015) (PubMed).

Ntokou, Klein, Dontireddy, Becker, Bellusci, Richardson, Szibor, Braun, Morty, Seeger, Voswinckel, Ahlbrecht: "Characterization of the platelet-derived growth factor receptor-α-positive cell lineage during murine late lung development." dans: American journal of physiology. Lung cellular and molecular physiology, Vol. 309, Issue 9, pp. L942-58, (2015) (PubMed).

Martin, Nakamura, Paila, Woo, Brown, Wright, Teraoka, Haghayegh, McCurdy, Schneider, Hu, Quinlan, Gatti, Concannon: "Homozygous mutation of MTPAP causes cellular radiosensitivity and persistent DNA double-strand breaks." dans: Cell death & disease, Vol. 5, pp. e1130, (2014) (PubMed).

Rosen, Leung, Louie, Cordeiro, Conroy, Shapira, Fields, Cesano, Hawtin: "Quantitative measurement of alterations in DNA damage repair (DDR) pathways using single cell network profiling (SCNP)." dans: Journal of translational medicine, Vol. 12, pp. 184, (2014) (PubMed).

Milner, Wombwell, Eckersley, Barnes, Warwicker, Van Dorp, Rowlinson, Dearden, Hughes, Harbron, Wellings, Hodgson, Womack, Gray, Lau, OConnor, Marsden, Kvist: "Validation of the BRCA1 antibody MS110 and the utility of BRCA1 as a patient selection biomarker in immunohistochemical analysis of breast and ovarian tumours." dans: Virchows Archiv : an international journal of pathology, Vol. 462, Issue 3, pp. 269-79, (2013) (PubMed).

Synonymes et noms alternatifs relatifs à BRCA1

BRCA1, DNA repair associated (BRCA1), breast cancer 1 (brca1), breast cancer 1, early onset (LOC755086), breast cancer 1, early onset (Brca1), BRCA1, DNA repair associated (Brca1), breast cancer 1, early onset (BRCA1), breast cancer 1 L homeolog (brca1.L), brca1, BRCA1, BRCAI, brcai, BRCC1, brcc1, BROVCA1, IRIS, iris, LOC100224649, PNCA4, PPP1R53, PSCP, pscp, RNF53, rnf53

Protein level used designations for BRCA1

  • BRCA1/BRCA2-containing complex, subunit 1
  • RING finger protein 53
  • breast and ovarian cancer susceptibility protein 1
  • breast and ovarian cancer sususceptibility protein 1
  • breast cancer type 1 susceptibility protein
  • protein phosphatase 1, regulatory subunit 53
  • BRCA1 homologue
  • breast cancer type 1 susceptibility protein homolog
  • breast cancer 1, early onset
  • BRCA1 homolog
  • breast and ovarian cancer susceptibility protein
  • breast cancer associated 1
Vous êtes ici:
Support technique